Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SEASPINE HOLDINGS CORPORATION

(SPNE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

SeaSpine : Launches NorthStar OCT Posterior Cervical Fixation System

10/11/2021 | 04:23pm EST


ę MT Newswires 2021
All news about SEASPINE HOLDINGS CORPORATION
11/23SeaSpine Discloses Commercial Rollout of Admiral ACP System
MT
11/23SeaSpine Announces Full Commercial Launch of the Admiral™ ACP System
AQ
11/23Seaspine Announces Full Commercial Launch of the Admiral? ACP System
CI
11/08SeaSpine to Participate in Upcoming Investor Conferences
AQ
11/03SEASPINE HOLDINGS CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
11/01SeaSpine Announces Limited Commercial Launch of Mariner MIS Wayfinder
AQ
11/01SeaSpine Holdings Corporation Announces Limited Commercial Launch of Mariner MIS Wayfin..
CI
10/28SEASPINE : Q3 Earnings Snapshot
AQ
10/28SeaSpine Reports Third Quarter 2021 Financial Results - Form 8-K
PU
10/28SeaSpine Holdings Corporation Provides Revenue Guidance for the Year 2021
CI
More news
Analyst Recommendations on SEASPINE HOLDINGS CORPORATION
More recommendations
Financials (USD)
Sales 2021 190 M - -
Net income 2021 -46,0 M - -
Net Debt 2021 - - -
P/E ratio 2021 -9,43x
Yield 2021 -
Capitalization 473 M 473 M -
Capi. / Sales 2021 2,49x
Capi. / Sales 2022 2,16x
Nbr of Employees 421
Free-Float 84,7%
Chart SEASPINE HOLDINGS CORPORATION
Duration : Period :
SeaSpine Holdings Corporation Technical Analysis Chart | SPNE | US81255T1088 | MarketScreener
Technical analysis trends SEASPINE HOLDINGS CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 12,97 $
Average target price 25,41 $
Spread / Average Target 95,9%
EPS Revisions
Managers and Directors
Keith C. Valentine President, Chief Executive Officer & Director
John J. Bostjancic Chief Financial Officer, Treasurer & Senior VP
Kirtley C. Stephenson Non-Executive Chairman
Chris Shen VP-Information Technology & Customer Experience
Frank Vizesi Vice President-Clinical Affairs
Sector and Competitors